Technical Analysis for MDP - Medexus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade C 4.21 5.25% 0.210
MDP closed up 5.25 percent on Wednesday, September 18, 2019, on 1.13 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical MDP trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
New Uptrend Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 5.25%

Older signals for MDP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.
Health Pharmaceutical Drugs Pharmaceutical Industry In China Cnx Nifty Allergy Immunosuppressants Pharmaceutical Business Sector Rheumatoid Arthritis
Is MDP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.08
52 Week Low 3.5
Average Volume 9,536
200-Day Moving Average 0.0
50-Day Moving Average 4.0838
20-Day Moving Average 3.7595
10-Day Moving Average 3.801
Average True Range 0.1868
ADX 38.65
+DI 27.0649
-DI 21.2934
Chandelier Exit (Long, 3 ATRs ) 3.6496
Chandelier Exit (Short, 3 ATRs ) 4.0604
Upper Bollinger Band 4.1644
Lower Bollinger Band 3.3546
Percent B (%b) 1.06
BandWidth 21.540098
MACD Line -0.0158
MACD Signal Line -0.0985
MACD Histogram 0.0827
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.600
Resistance 3 (R3) 4.557 4.383 4.535
Resistance 2 (R2) 4.383 4.284 4.405 4.513
Resistance 1 (R1) 4.297 4.223 4.340 4.340 4.492
Pivot Point 4.123 4.123 4.145 4.145 4.123
Support 1 (S1) 4.037 4.024 4.080 4.080 3.928
Support 2 (S2) 3.863 3.963 3.885 3.907
Support 3 (S3) 3.777 3.863 3.885
Support 4 (S4) 3.820